Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection

MUMBAI, India and NAPLES, Fla., June 4, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizumab,...